肾结石管理市场规模、份额、成长分析、按类型、按治疗类型、按诊断、按最终用户、按地区 - 行业预测，2025 年至 2032 年

2023 年全球肾结石管理市场规模价值 20.6 亿美元，预计将从 2024 年的 22 亿美元成长到 2032 年的 37.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.0%。

由于全球肾结石病例数量的增加，全球肾结石管理市场正经历强劲成长。人们对利用震波碎石术、输尿管镜检查和经皮穿刺取石术等先进技术的创新治疗方案的需求日益增加，以加快恢復速度并最大限度地减少不适。市场越来越倾向于微创技术，包括雷射碎石术和机器人辅助手术，以确保精准定位并改善患者治疗效果。此外，针对预防復发、缓解疼痛等新药的研发也不断进展。虽然北美由于高渗透率和支持性报销政策而占据主导地位，但随着医疗保健基础设施和意识的改善，亚太地区预计将呈现最快的成长。总体而言，由于技术进步和策略性地理扩张，市场正在呈现良好的发展轨迹。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

肾结石管理市场规模（按类型）

• 市场概况
• 草酸钙结石
• 尿酸
• 鸟粪石肾结石
• 胱氨酸结石
• 磷酸钙结石

肾结石管理市场规模（依治疗类型）

• 市场概况
• 药品
• 体外震波碎石术
• 输尿管镜检查
• 经皮肾镜取石术

肾结石管理市场规模（依诊断）

• 市场概况
• 特殊超音波
• 静脉肾盂造影
• 电脑断层扫描
• X 射线
• 其他的

肾结石管理市场规模（按最终用户）

• 市场概况
• 医院
• 专科门诊
• 门诊手术中心

肾结石管理市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Boston Scientific Corporation（United States）
• Olympus Corporation（Japan）
• KARL STORZ SE & Co. KG（Germany）
• Cook Medical Inc.（United States）
• Dornier MedTech GmbH（Germany）
• Richard Wolf GmbH（Germany）
• Stryker Corporation（United States）
• Siemens Healthineers AG（Germany）
• Becton, Dickinson and Company（BD）（United States）
• Coloplast A/S（Denmark）
• DirexGroup（United States）
• Storz Medical AG（Switzerland）
• Allengers Medical Systems Ltd（India）
• CR Bard Inc.（United States）
• EDAP TMS（France）
• Convergent Laser Technologies（United States）
• HealthTronics, Inc.（United States）
• United Medical Systems（DE）, Inc.（United States）
• Advanced MedTech Holdings（Singapore）
• Calyxo, Inc.（United States）

结论和建议

Global Kidney Stones Management Market size was valued at USD 2.06 billion in 2023 and is poised to grow from USD 2.2 billion in 2024 to USD 3.79 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

The Global Kidney Stones Management Market is experiencing robust growth, driven by a rising incidence of kidney stone cases globally. There is an escalating demand for innovative treatment options, leveraging advanced technologies like shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy that enhance recovery and minimize discomfort. The market is increasingly leaning towards minimally invasive techniques, including laser lithotripsy and robotic-assisted surgeries, which ensure precise targeting and improved patient outcomes. Additionally, substantial research and development efforts are yielding new pharmaceuticals aimed at preventing recurrence and alleviating pain. Dominated by North America due to high prevalence and supportive reimbursement policies, the Asia-Pacific region is predicted to exhibit the fastest growth, propelled by enhanced healthcare infrastructure and awareness. Overall, this market demonstrates a promising trajectory marked by technological advancement and strategic regional expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Kidney Stones Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Kidney Stones Management Market Segmental Analysis

Global Kidney Stones Management Market is segmented by Type, Treatment Type, Diagnosis, End User and region. Based on Type, the market is segmented into Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones and Calcium Phosphate Stones. Based on Treatment Type, the market is segmented into Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy and Percutaneous Nephrolithotomy. Based on Diagnosis, the market is segmented into Specialty Ultrasound, Intravenous Pyelography, CT Scan, X-Ray and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Kidney Stones Management Market

A major driver of the Global Kidney Stones Management Market is the escalating incidence of kidney stone cases across the globe. The rising number of individuals affected by this condition is creating an urgent need for effective treatment solutions, thereby fueling advancements in medical technology and innovative procedures. As more people face challenges related to kidney stones, there is heightened attention towards research and development to enhance current treatment methodologies and unveil new interventions. This growing prevalence not only highlights the necessity for better management options but also propels market expansion as healthcare providers strive to meet the increasing demand for reliable kidney stone therapies.

Restraints in the Global Kidney Stones Management Market

A significant challenge facing the Global Kidney Stones Management Market is the elevated costs linked to specific treatment procedures and technologies. Although advanced options, like robotic-assisted surgeries and laser lithotripsy, provide substantial advantages in precision and patient outcomes, their high price can be prohibitive. Furthermore, many of these advanced treatments may lack availability or insurance coverage in certain areas, restricting access for patients with limited financial means. This financial barrier can impede the broader acceptance and implementation of advanced treatment methods, consequently affecting the overall growth potential of the market.

Market Trends of the Global Kidney Stones Management Market

The Global Kidney Stones Management market is witnessing a significant trend towards the increasing adoption of robotic-assisted surgeries for kidney stone removal. Innovations in robotic platforms, like Ethicon's MONARCH system, are becoming increasingly favored in urology for their precision and ability to minimize procedural complications. By integrating advanced robotic technologies, surgeons can execute more accurate and controlled maneuvers, which leads to improved patient outcomes and decreased rates of retreatment. This trend underscores the industry's commitment to harnessing cutting-edge technology, enhancing the overall efficacy and safety of kidney stone management procedures, and ultimately transforming patient care in this field.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Kidney Stones Management Market Size by Type & CAGR (2025-2032)

• Market Overview
• Calcium Oxalate Stones
• Uric Acid
• Struvite Kidney Stones
• Cystine Stones
• Calcium Phosphate Stones

Global Kidney Stones Management Market Size by Treatment Type & CAGR (2025-2032)

• Market Overview
• Medications
• Extracorporeal Shock Wave Lithotripsy
• Ureteroscopy
• Percutaneous Nephrolithotomy

Global Kidney Stones Management Market Size by Diagnosis & CAGR (2025-2032)

• Market Overview
• Specialty Ultrasound
• Intravenous Pyelography
• CT Scan
• X-Ray
• Others

Global Kidney Stones Management Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Global Kidney Stones Management Market Size & CAGR (2025-2032)

• North America (Type, Treatment Type, Diagnosis, End User)
  • US
  • Canada
• Europe (Type, Treatment Type, Diagnosis, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment Type, Diagnosis, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment Type, Diagnosis, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment Type, Diagnosis, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DirexGroup (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Storz Medical AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allengers Medical Systems Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.R. Bard Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convergent Laser Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthTronics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Medical Systems (DE), Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced MedTech Holdings (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calyxo, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations